Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

New drug, Vemurafenib, doubles survival of metastatic melanoma patients

New drug, Vemurafenib, doubles survival of metastatic melanoma patients

New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of people dying from the disease is declining

New estimates predict nearly 1.3 million deaths from cancer in the EU in 2012, but the rate of people dying from...

Novel molecules to fight cancer resistance

Novel molecules to fight cancer resistance

Study reveals variation in how quickly doctors refer suspected cancer patients

Study reveals variation in how quickly doctors refer suspected cancer patients

Women, young people and ethnic minorities most difficult to diagnose with cancer

Women, young people and ethnic minorities most difficult to diagnose with cancer

Newly approved drug for metastatic melanoma nearly doubles median survival

Newly approved drug for metastatic melanoma nearly doubles median survival

ecancermedicalscience indexed in PubMed

ecancermedicalscience indexed in PubMed

Combination therapy offers potential in colon cancers with BRAF mutations

Combination therapy offers potential in colon cancers with BRAF mutations

Cell senescence does not stop tumour growth

Cell senescence does not stop tumour growth

Scientists uncover reason for second cancers after targeted melanoma treatment

Scientists uncover reason for second cancers after targeted melanoma treatment

More from ecancer